Schwarzer Cardiotek

2018-08-21T13:29:17+00:00

Thomas R. Villinger

ZFHN Partner:

2008

Initial investment:

Schwarzer Cardiotek develops, produces and distributes hemodynamic and electrophysiological measuring systems and data-management solutions for the interventional cardiology field.

Frank-Peter Klein

President and Chief Executive Officer

Thomas R. Villinger

ZFHN Partner:

2008

Initial investment:

Schwarzer Cardiotek develops, produces and distributes hemodynamic and electrophysiological measuring systems and data-management solutions for the interventional cardiology field.

Frank-Peter Klein

President and Chief Executive Officer

Schwarzer Cardiotek develops, produces and distributes hemodynamic and electrophysiological measuring systems and data-management solutions for the interventional cardiology field.

With more than 1,000 hemodynamic installations and over 900 installed EP systems, and after 60 successful years in the marketplace, the company is known for strong partnerships in the cardiology field.

Due to the support from ZFHN, we were able to both invest in our innovative capacities and professionalize our internal processes. ZFHN has been a sparring partner for us both in terms of business in general as well as with regard to the content of our particular business dealing with products in the medical technology field.

Frank-Peter Klein

President and Chief Executive Officer

Due to the support from ZFHN, we were able to both invest in our innovative capacities and professionalize our internal processes. ZFHN has been a sparring partner for us both in terms of business in general as well as with regard to the content of our particular business dealing with products in the medical technology field.

Frank-Peter Klein

President and Chief Executive Officer

1951
Founding of the Fritz Schwarzer GmbH in Munich
1968
The first industrially produced device for multichannel EEG analysis
1969
Sale of Schwarzer GmbH to the American Optical company, continued existence of a company called Schwarzer G.m.b.H.
1988
Development of the first digitally functioning EEG device in the world that features signal transmission utilizing fiber optics
2001
Founding of the CardioTek company as a spin-off from the University of Maastricht
2002
CardioTek introduces the first laptop-based EP system worldwide – the EP-Tracer Portable, a mobile version of the EP-Tracer.
2008
Relocation of company headquarters; Schwarzer GmbH is managed from now on under the umbrella of the Zukunftsfonds in Heilbronn
2010
Schwarzer GmbH moves the rest of its offices and operations from Munich to the Zukunftspark in Heilbronn
2014
Product partnership between Schwarzer GmbH and the Dutch company CardioTek, based in Maastricht, leads to the legal merger of the two companies under the new name of Schwarzer Cardiotek GmbH
2015
A new software version of the EP-Tracer 2, which, among other things, makes possible the integration of cryoablators. The EP-Tracer is marketed in Europe, Central and South America, the USA, the Asia-Pacific area, and in the Near and Middle East.
2016
FDA approval for the EP-Tracer 2
2017
EP-Tracer 2.2 software release